BeiGene, Ltd. (NASDAQ: ONC) reported Q4 EPS of ($0.11), $0.77 better than the analyst estimate of ($0.88). Revenue for the quarter came in at $1.13 billion versus the consensus estimate of $1.05 billion.

GUIDANCE:

BeiGene, Ltd. sees FY2025 revenue of $4.9-5.3 billion, versus the consensus of $4.742 billion.

For earnings history and earnings-related data on BeiGene, Ltd. (ONC) click here.